The Global Fund for HIV, TB, and Malaria has reaffirmed its commitment to rolling out the twice-yearly HIV prevention jab, lenacapavir, in lower-income countries, including South Africa. This initiative will continue with or without the support of the US President’s Emergency Plan for AIDS Relief (Pepfar), which recently encountered funding disruptions during President Donald Trump’s term. According to Global Fund…
Tag: HIV Prevention
-
Trump’s USAID cuts threaten SA’s HIV/AIDS progress
In a devastating move for South Africa’s healthcare sector, former US President Donald Trump rescinded all USAID grants supporting HIV/AIDS programs in the country. The decision, announced on Thursday, has put thousands of healthcare jobs at risk and threatens the progress made in battling the epidemic. Health activists warn that the cuts could reverse years of hard-won gains, leaving vulnerable…
-
Lenacapavir injection: The new frontier in HIV prevention
At the 5th HIV Research for Prevention Conference (HIVR4P) in Peru, groundbreaking data on the lenacapavir injection revealed its remarkable efficacy in HIV prevention. With a single injection every six months, the drug completely halted new HIV infections among women and girls. It achieved a 96% risk reduction for other gender-diverse individuals aged 16 and up. Despite lenacapavir’s transformative potential,…